Latest News and Press Releases

BRIDGEWATER, N.J., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the appointment of Mark...

BRIDGEWATER, N.J., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the appointment of Mark...

BRIDGEWATER, N.J., Dec. 20, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the launch of Colvera™, a...

BRIDGEWATER, N.J., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-driven diagnostic tools for colorectal cancer, today announced the appointment of...

BRIDGEWATER, N.J., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing innovative healthcare solutions for cancer diagnosis, today announced the appointments of Laurie...

BRIDGEWATER, N.J., Oct. 12, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, today announced that data supporting its...

BRIDGEWATER, N.J., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, marks a decade of discovery and innovation as...

BRIDGEWATER, N.J. and SALT LAKE CITY, June 02, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing advanced diagnostic tools for colorectal cancer, today announced that it has...

Investment will support commercialization of company’s blood-based test for colorectal cancer recurrence Appoints Dr. Paul Kelly to board of directors EDISON, N.J., March 23, 2016 (GLOBE...

EDISON, N.J., Jan. 25, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing next-generation diagnostic tools for colorectal cancer, today announced new data supporting its 2-gene...